These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis. Zuo J; Ishikawa T; Boutros S; Xiao Z; Humtsoe JO; Kramer RH Mol Cancer Res; 2010 Feb; 8(2):170-82. PubMed ID: 20145039 [TBL] [Abstract][Full Text] [Related]
7. Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Andersen H; Mejlvang J; Mahmood S; Gromova I; Gromov P; Lukanidin E; Kriajevska M; Mellon JK; Tulchinsky E Mol Cell Biol; 2005 Oct; 25(20):9138-50. PubMed ID: 16199889 [TBL] [Abstract][Full Text] [Related]
8. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. Islam S; Carey TE; Wolf GT; Wheelock MJ; Johnson KR J Cell Biol; 1996 Dec; 135(6 Pt 1):1643-54. PubMed ID: 8978829 [TBL] [Abstract][Full Text] [Related]
9. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related]
10. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition. Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758 [TBL] [Abstract][Full Text] [Related]
11. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions. Chiles MC; Ai L; Zuo C; Fan CY; Smoller BR Mod Pathol; 2003 Oct; 16(10):1014-8. PubMed ID: 14559984 [TBL] [Abstract][Full Text] [Related]
12. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. Vizirianakis IS; Chen YQ; Kantak SS; Tsiftsoglou AS; Kramer RH Int J Oncol; 2002 Jul; 21(1):135-44. PubMed ID: 12063560 [TBL] [Abstract][Full Text] [Related]
13. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258 [TBL] [Abstract][Full Text] [Related]
14. Suppression of E-cadherin function drives the early stages of Ras-induced squamous cell carcinoma through upregulation of FAK and Src. Alt-Holland A; Sowalsky AG; Szwec-Levin Y; Shamis Y; Hatch H; Feig LA; Garlick JA J Invest Dermatol; 2011 Nov; 131(11):2306-15. PubMed ID: 21716326 [TBL] [Abstract][Full Text] [Related]
15. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Santos-García A; Abad-Hernández MM; Fonseca-Sánchez E; Julián-González R; Galindo-Villardón P; Cruz-Hernández JJ; Bullón-Sopelana A Med Oral Patol Oral Cir Bucal; 2006 Mar; 11(2):E100-5. PubMed ID: 16505783 [TBL] [Abstract][Full Text] [Related]
16. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells. Fujii K; Furukawa F; Matsuyoshi N Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495 [TBL] [Abstract][Full Text] [Related]
17. Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo. Andl CD; Fargnoli BB; Okawa T; Bowser M; Takaoka M; Nakagawa H; Klein-Szanto A; Hua X; Herlyn M; Rustgi AK Cancer Res; 2006 Oct; 66(20):9878-85. PubMed ID: 17047049 [TBL] [Abstract][Full Text] [Related]
18. E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents. Alt-Holland A; Shamis Y; Riley KN; DesRochers TM; Fusenig NE; Herman IM; Garlick JA J Invest Dermatol; 2008 Oct; 128(10):2498-507. PubMed ID: 18528437 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton. Frontelo P; González-Garrigues M; Vilaró S; Gamallo C; Fabra A; Quintanilla M Exp Cell Res; 1998 Nov; 244(2):420-32. PubMed ID: 9806792 [TBL] [Abstract][Full Text] [Related]
20. A causal role for E-cadherin in the transition from adenoma to carcinoma. Perl AK; Wilgenbus P; Dahl U; Semb H; Christofori G Nature; 1998 Mar; 392(6672):190-3. PubMed ID: 9515965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]